These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32293456)

  • 1. HDL functions and their interaction in patients with ST elevation myocardial infarction: a case control study.
    Thakkar H; Vincent V; Roy A; Singh S; Ramakrishnan L; Kalaivani M; Singh A
    Lipids Health Dis; 2020 Apr; 19(1):75. PubMed ID: 32293456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.
    Furuyama F; Koba S; Yokota Y; Tsunoda F; Shoji M; Kobayashi Y
    J Atheroscler Thromb; 2018 Feb; 25(2):153-169. PubMed ID: 28855433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
    Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A
    J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
    Murakami H; Tanabe J; Tamasawa N; Matsumura K; Yamashita M; Matsuki K; Murakami H; Matsui J; Suda T
    Diabetes Res Clin Pract; 2013 Jan; 99(1):30-8. PubMed ID: 23137417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
    Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
    Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS.
    Cordero A; Muñoz-García N; Padró T; Vilahur G; Bertomeu-González V; Escribano D; Flores E; Zuazola P; Badimon L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.
    Blatter Garin MC; Moren X; James RW
    J Lipid Res; 2006 Mar; 47(3):515-20. PubMed ID: 16327022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia.
    Zhu Y; Huang X; Zhang Y; Wang Y; Liu Y; Sun R; Xia M
    J Clin Endocrinol Metab; 2014 Feb; 99(2):561-9. PubMed ID: 24285687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
    Guerin M; Silvain J; Gall J; Darabi M; Berthet M; Frisdal E; Hauguel-Moreau M; Zeitouni M; Kerneis M; Lattuca B; Brugier D; Collet JP; Lesnik P; Montalescot G
    J Am Coll Cardiol; 2018 Dec; 72(25):3259-3269. PubMed ID: 30573028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.
    Charles-Schoeman C; Lee YY; Grijalva V; Amjadi S; FitzGerald J; Ranganath VK; Taylor M; McMahon M; Paulus HE; Reddy ST
    Ann Rheum Dis; 2012 Jul; 71(7):1157-62. PubMed ID: 22267330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Antiatherogenic Functions of High-density Lipoprotein in Patients with Ankylosing Spondylitis.
    Gkolfinopoulou C; Stratikos E; Theofilatos D; Kardassis D; Voulgari PV; Drosos AA; Chroni A
    J Rheumatol; 2015 Sep; 42(9):1652-60. PubMed ID: 26233507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.
    Kidawa M; Gluba-Brzózka A; Zielinska M; Franczyk B; Banach M; Rysz J
    Curr Vasc Pharmacol; 2019; 17(4):365-375. PubMed ID: 29852873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.